Corporate Office HQ

Medical

Dentsply International Corporate Office

Dentsply International has its roots in the 1899 founding of Dentists’ Supply Company by George H. Whitely and three business partners. The company quickly acquired a Pennsylvania porcelain teeth manufacturer.

Whitely was a ceramist and operated the company due to his invaluable experience and important innovations such as using platinum rings to reduce tooth breakage, better fitting dentures, age specific colored teeth, and changing the size of manufactured teeth to fit the size of people’s heads and face shapes.

Today Dentsply International manufactures a broad range of dental products including crown and bridge materials, implants, tooth whiteners for artificial teeth, anesthetics, pastes, artificial teeth, root canal instruments, orthodontic appliances, ultrasonic polishers, and X-ray viewers.

The company sells its products through distributors as well as directly to dentists, dental schools, and dental labs.

Dentsply International trades publicly on the NASDAQ under the ticker symbol XRAY, is a member of the S&P 500, is #734 in the Fortune 1000, has 11,800 employees, and had $2.96 billion in revenue in 2014.

 

Dentsply International

Dentsply International has its roots in the 1899 founding of Dentists’ Supply Company by George H. Whitely and three business partners. The company quickly acquired a Pennsylvania porcelain teeth manufacturer.

Whitely was a ceramist and operated the company due to his invaluable experience and important innovations such as using platinum rings to reduce tooth breakage, better fitting dentures, age specific colored teeth, and changing the size of manufactured teeth to fit the size of people’s heads and face shapes.

Today Dentsply International manufactures a broad range of dental products including crown and bridge materials, implants, tooth whiteners for artificial teeth, anesthetics, pastes, artificial teeth, root canal instruments, orthodontic appliances, ultrasonic polishers, and X-ray viewers.

History

The company sells its products through distributors as well as directly to dentists, dental schools, and dental labs.

Dentsply International trades publicly on the NASDAQ under the ticker symbol XRAY, is a member of the S&P 500, is #734 in the Fortune 1000, has 11,800 employees, and had $2.96 billion in revenue in 2014.

 

Select Medical Corporation Corporate Office

Select Medical Corporation operates inpatient rehabilitation centers inside general hospitals. Most patients are referred from the hospitals.

The centers specialize in treating complex medical conditions that require long-term care.

The company also offers contract rehabilitation services at nursing homes and operates 1,000 outpatient rehabilitation clinics in 32 states.

Select Medical Corporation operates 100 centers at long-term acute care hospitals and 16 inpatient rehabilitation locations in 28 states.

The company trades publicly on the New York Stock Exchange under the ticker symbol SEM, is #730 in the Fortune 1000, is a member of the Russell 2000, has 21,100 employees, and had $3 billion in revenue in 2014.

In January 2022, the company announced an estimated date when it expected to release its finanical earnings. 

Select Medical Corporation maintains a corporate office in Mechanicsburg, Pennsylvania.

Select Medical Corporation

Select Medical Corporation operates inpatient rehabilitation centers inside general hospitals. Most patients are referred from the hospitals.

The centers specialize in treating complex medical conditions that require long-term care.

History

The company also offers contract rehabilitation services at nursing homes and operates 1,000 outpatient rehabilitation clinics in 32 states.

Select Medical Corporation operates 100 centers at long-term acute care hospitals and 16 inpatient rehabilitation locations in 28 states.

The company trades publicly on the New York Stock Exchange under the ticker symbol SEM, is #730 in the Fortune 1000, is a member of the Russell 2000, has 21,100 employees, and had $3 billion in revenue in 2014.

In January 2022, the company announced an estimated date when it expected to release its finanical earnings. 

Select Medical Corporation maintains a corporate office in Mechanicsburg, Pennsylvania.

Alere Corporate Office

Alere  was founded in 1991 by Ron Zwanziger as SelfCare, SelfCare went public in 1996 and changed its name to Inverness Medical Technology (IMT) in 2000.

In 2001 the company sold its diabetes business to Johnson & Johnson and began to expand its remaining business through acquisitions of companies such as Wampole Laboratories, Ostex International, Binax, and Axis-Shield.

In 2004 the company launched the world’s first digital pregnancy test with Clearblue Digital Pregnancy Test.

Today Alere, as the company has been known since 2010, offers professional and consumer diagnostic tests, including tests for cancer, cardiovascular disease, drug abuse, infectious disease, lipid and cholesterol, HIV, tuberculosis, hepatitis B, and women’s health including pregnancy tests and fertility monitors.

Alere trades publicly on the New York Stock Exchange under the ticker symbol ALR, is #725 in the Fortune 1000, has 17,600 employees, and had $2.96 billion in revenue in 2014.

Alere

Alere  was founded in 1991 by Ron Zwanziger as SelfCare, SelfCare went public in 1996 and changed its name to Inverness Medical Technology (IMT) in 2000.

In 2001 the company sold its diabetes business to Johnson & Johnson and began to expand its remaining business through acquisitions of companies such as Wampole Laboratories, Ostex International, Binax, and Axis-Shield.

In 2004 the company launched the world’s first digital pregnancy test with Clearblue Digital Pregnancy Test.

History

Today Alere, as the company has been known since 2010, offers professional and consumer diagnostic tests, including tests for cancer, cardiovascular disease, drug abuse, infectious disease, lipid and cholesterol, HIV, tuberculosis, hepatitis B, and women’s health including pregnancy tests and fertility monitors.

Alere trades publicly on the New York Stock Exchange under the ticker symbol ALR, is #725 in the Fortune 1000, has 17,600 employees, and had $2.96 billion in revenue in 2014.

C. R. Bard Corporate Office

C. R. Bard was founded in 1907 by Charles R. Bard as an importer of Gomenol, a medication used to treat urinary discomfort.

In 1928 Bard sold the company to John F. Willits and Edson L. Outwin, who expanded the business by selling the Foley catheter in 1934 and the American Woven Catheter in 1940.

In 1948 C. R. Bard’s sales reached $1 million for the first time. At the same time the company continued to innovate in with new and better types of catheters.

Today the company’s Foley urological catheter is still a best seller. C. R. Bard operates through four divisions: Vascular, Oncology, Urology, and Surgical Specialties. Products include stents, catheters for delivering chemotherapy treatments, urology catheters, specialty surgical tools, and guidewires used in angioplasties and other vascular procedures.

C. R. Bard trades publicly on the New York Stock Exchange under the ticker symbol BCR, is a member of the S&P 500, is #720 in the Fortune 1000, and had $3.32 billion in revenue in 2014.

C. R. Bard

C. R. Bard was founded in 1907 by Charles R. Bard as an importer of Gomenol, a medication used to treat urinary discomfort.

In 1928 Bard sold the company to John F. Willits and Edson L. Outwin, who expanded the business by selling the Foley catheter in 1934 and the American Woven Catheter in 1940.

In 1948 C. R. Bard’s sales reached $1 million for the first time. At the same time the company continued to innovate in with new and better types of catheters.

History

Today the company’s Foley urological catheter is still a best seller. C. R. Bard operates through four divisions: Vascular, Oncology, Urology, and Surgical Specialties. Products include stents, catheters for delivering chemotherapy treatments, urology catheters, specialty surgical tools, and guidewires used in angioplasties and other vascular procedures.

C. R. Bard trades publicly on the New York Stock Exchange under the ticker symbol BCR, is a member of the S&P 500, is #720 in the Fortune 1000, and had $3.32 billion in revenue in 2014.

Biomet Corporate Office

Biomet was founded by Dane A. Miller, Ray Harroff, Niles Noblitt, and Jerry Ferguson in 1977 to manufacture and market medical products and devices.

The company was acquired in 2007 by a group of private equity investors and taken private after having traded on the NASDAQ. The company continues to operate as Biomet but the name was changed to LVB Acquisitions after the acquisition.

Today Biomet makes medical devices including hip, knee, and shoulder reconstructive products, dental implants, bone cement systems, orthopedic support devices, operating room supplies, electrical bone-growth stimulators, bone grafting  materials, and fixation devices such as bone screws and pins.

Biomet is #719 in the Fortune 1000, is #142 in the Forbes list of America’s Largest Private Companies, has 9,200 employees, and had $3.22 billion in revenue in 2014.

Biomet

Biomet was founded by Dane A. Miller, Ray Harroff, Niles Noblitt, and Jerry Ferguson in 1977 to manufacture and market medical products and devices.

The company was acquired in 2007 by a group of private equity investors and taken private after having traded on the NASDAQ. The company continues to operate as Biomet but the name was changed to LVB Acquisitions after the acquisition.

Today Biomet makes medical devices including hip, knee, and shoulder reconstructive products, dental implants, bone cement systems, orthopedic support devices, operating room supplies, electrical bone-growth stimulators, bone grafting  materials, and fixation devices such as bone screws and pins.

History

Biomet is #719 in the Fortune 1000, is #142 in the Forbes list of America’s Largest Private Companies, has 9,200 employees, and had $3.22 billion in revenue in 2014.